Breaking News
Genentech to Reintroduce Susvimo Ocular Implant for Wet AMD

Genentech announced the reintroduction of Susvimo (ranibizumab injection) 100 mg/mL for intravitreal...

read more
Genentech to Reintroduce Susvimo Ocular Implant for Wet AMD
July 17, 2024
Outlook Therapeutics Receives UK Approval of Lytenava for Wet AMD Treatment

Outlook Therapeutics announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA...

read more
Outlook Therapeutics Receives UK Approval of Lytenava for Wet AMD Treatment
July 16, 2024
Novo Nordisk’s Popular Weight Loss Drugs Linked to Higher Risk of NAION

A recent study by Mass Eye and Ear links semaglutide (Ozempic, Wegovy) from Novo Nordisk to higher N...

read more
Novo Nordisk’s Popular Weight Loss Drugs Linked to Higher Risk of NAION
July 04, 2024
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®

Formycon AG and its licensing partner Klinge Biopharma GmbH announced the U.S. Food and Drug Adminis...

read more
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®
July 03, 2024
Roche’s Vabysmo Receives CHMP Recommendation for RVO Indication

Roche announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medic...

read more
Roche’s Vabysmo Receives CHMP Recommendation for RVO Indication
July 02, 2024
EMA’s CHMP Issues Negative Opinion on Syfovre for GA; Apellis to Pursue Re-Examination

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) del...

read more
EMA’s CHMP Issues Negative Opinion on Syfovre for GA; Apellis to Pursue Re-Examination
July 01, 2024
FDA Grants DeNovo Classification to FYSX™ Ocular Pressure Adjusting Pump

Balance Ophthalmics has been granted FDA’s DeNovo Classification to their FYSX™ Ocular Pressure Adju...

read more
FDA Grants DeNovo Classification to FYSX™ Ocular Pressure Adjusting Pump
July 01, 2024
ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal

ANI Pharmaceutical and Alimera Sciences announced a definitive agreement for ANI to acquire Alimera ...

read more
ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal
June 25, 2024
FDA Clears Alcon's Unity Vitreoretinal-Cataract System and Unity Standalone Cataract System

Alcon has received FDA 510(k) clearance for its Unity Vitreoretinal Cataract System (VCS) and Unity ...

read more
FDA Clears Alcon's Unity Vitreoretinal-Cataract System and Unity Standalone Cataract System
June 25, 2024
Aurion Biotech's AURN001 Receives FDA Breakthrough and RMAT Designations for Corneal Edema Therapy

Aurion Biotech has been granted Breakthrough Therapy Designation (BTD) and Regenerative Medicine Adv...

read more
Aurion Biotech's AURN001 Receives FDA Breakthrough and RMAT Designations for Corneal Edema Therapy
June 21, 2024
More